HB2680 amends the Illinois Insurance Code to change how prescription drug payments are counted toward a person’s health plan cost-sharing limits. For any health or accident insurance plan that covers prescription drugs and is issued, amended, renewed, or delivered on or after January 1, 2027, the bill requires insurers to count amounts paid by the insured or paid on the insured’s behalf by another person toward the insured’s out-of-pocket maximum or other cost-sharing requirement.
The bill is aimed at reducing the financial burden on insured individuals who receive help paying for prescription drugs, including assistance from family members, charities, or other third parties. It creates an exception for high-deductible health plans when compliance would make the plan ineligible for a health savings account, preserving federal HSA compatibility for those plans.
Impact
HB2680 would add a new Section 356z.80 to the Illinois Insurance Code and require affected health and accident insurance policies to treat third-party prescription drug payments as counting toward deductibles, out-of-pocket maximums, or similar cost-sharing thresholds. This would affect insurers, plan administrators, and insureds with prescription drug coverage beginning with policies issued, renewed, amended, or delivered on or after January 1, 2027. The bill also preserves an exception for high-deductible health plans where counting those payments would jeopardize HSA eligibility.
Sentiment
Based on the bill text and the absence of recorded committee debate or votes, the measure appears to be a consumer-protection and affordability proposal with a generally favorable policy orientation toward lowering prescription drug costs for patients. There is no documented opposition or recorded vote history in the provided materials, so no formal legislative sentiment can be inferred beyond the bill’s apparent intent.
Contention
The main policy issue is whether insurers should be required to credit third-party prescription assistance toward a patient’s cost-sharing limits. Supporters would likely view this as helping patients reach out-of-pocket caps sooner and improving affordability, while potential critics may raise concerns about premium impacts, plan administration, or interactions with pharmacy assistance programs. The bill specifically addresses a likely point of contention by exempting high-deductible health plans when necessary to preserve health savings account eligibility.